Physician profile
Ivan Lamotta
NPI 1598803462
$299,265.37
in general payments reported to CMS, 2019-2025
26 companies · $28K in 2025
The $28K reported for 2025 was more than what 82% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57K · 2020: $79K · 2021: $44K · 2022: $46K · 2023: $30K · 2024: $15K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $45K · Consulting Fee: $23K · Food and Beverage: $2,387 · Travel and Lodging: $1,952.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $45,351.71 |
| Consulting Fee | $23,432.50 |
| Food and Beverage | $2,387.25 |
| Travel and Lodging | $1,951.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $252,166.65 | 2019-2025 | Must, Myspine, Amistem |
| Globus Medical, INC. | $23,099.77 | 2019-2025 | Monument, Monument, Hedron |
| Mirus, LLC | $19,203.46 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $1,067.48 | 2019-2021 | |
| Nuvasive, INC. | $965.59 | 2019-2023 | Simplify Cervical Artificial Disc, Xlif, Modulus |
| Medtronic, INC. | $606.35 | 2022-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Osteocool Rf Ablation System |
| Circinus Medical Technology LLC | $366.93 | 2025 | Bolt Navigation |
| Abbott Laboratories | $303.41 | 2021-2025 | Penta, Eterna, Octrode |
| Curiteva, INC. | $286.63 | 2023 | |
| Si-Bone, INC. | $266.91 | 2019-2022 | |
| Medtronic USA, INC. | $182.79 | 2019-2020 | |
| Providence Medical Technology, INC. | $150.61 | 2020-2021 | |
| Kuros Biosciences USA, INC | $130.59 | 2025 | Magnetos |
| Brainlab, INC. | $122.13 | 2021 | |
| Smith+Nephew, INC. | $54.08 | 2022-2024 | Real Intelligence |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $49.14 | 2019-2021 | |
| Pacira Therapeutics, INC. | $38.84 | 2019-2020 | |
| Depuy Synthes Sales INC. | $38.63 | 2020-2021 | |
| Radius Health, INC. | $34.46 | 2021 | |
| Heron Therapeutics, INC. | $32.39 | 2022 | |
| Innovation Technologies INC | $21.58 | 2022 | |
| Avanos Medical | $19.21 | 2022 | |
| Bioventus LLC | $16.88 | 2021 | |
| Boston Scientific Corporation | $16.08 | 2019 | |
| Orthofix Medical, INC. | $13.29 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $11.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivan Lamotta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.